News and Updates

Novel Mutiple Sclerosis Stem Cell Study Begins

A small group of patients with multiple sclerosis were enrolled in a new pilot clinical trial to test bone marrow stem cell therapy at Frenchay Hospital. The aim of the trial is to find out what effects, good or bad, it has on patients with MS, and their disability. It is being conducted by the University of Bristol and North Bristol NHS Trust.

Read More »

Take the first step towards the healthier life you deserve.

The Stem Cell Institute has integrated Intranasal MTF Therapy into its autism protocol:

  • MTF therapy features exosomes and over 300 beneficial molecules
  • Works in synergy with our stem cells
  • Offers anti-inflammatory and regenerative effects
  • Delivered in an easy-to-administer aerosol format via the nose
  • To discover more about MTF and its benefits, click here